Skip to main content

Table 2 Age-adjusted odds ratios of mastectomy to lumpectomy between breast cancer biologic subtypes for T1 tumors stratified by race and T2 tumors

From: Her2 positivity and race predict higher mastectomy rates: a SEER database analysis

T1

White

Black

Other

T2

OR (95 % CI)

OR (95 % CI)

OR (95 % CI)

OR (95 % CI)

Her2+/HR+ vs Her2+/HR−

0.63 (0.57, 0.70)

0.86 (0.65, 1.13)

0.61 (0.47, 0.80)

Her2+/HR+ vs Her2+/HR−

0.66 (0.60, 0.72)

Her2+/HR+ vs Her2−/HR+

1.44 (1.36, 1.53)

1.30 (1.10, 1.52)

1.33 (1.12, 1.57)

Her2+/HR+ vs Her2−/HR+

1.42 (1.34, 1.50)

Her2+/HR+ vs triple negative

1.20 (1.10, 1.30)

1.42 (1.16, 1.72)

1.12 (0.88, 1.44)

Her2+/HR+ vs triple negative

1.22 (1.14, 1.32)

Her2+/HR− vs Her2−/HR+

2.28 (2.08, 2.50)

1.51 (1.19, 1.91)

2.17 (1.72, 2.74)

Her2+/HR− vs Her2−/HR+

2.16 (1.99, 2.34)

Her2+/HR− vs triple negative

1.89 (1.69, 2.10)

1.65 (1.27, 2.14)

1.84 (1.37, 2.47)

Her2+/HR− vs triple negative

1.87 (1.70, 2.05)

Her2−/HR+ vs triple negative

0.83 (0.78, 0.88)

1.09 (0.95, 1.26)

0.85 (0.69, 1.04)

Her2−/HR+ vs triple negative

0.86 (0.82, 0.91)